You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for Patent: 8,846,066


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,846,066
Title:Methods and related compositions for reduction of fat and skin tightening
Abstract:Compositions and methods useful in the reduction of localized fat deposits and tightening of loose skin in subjects in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion or anti-dispersion agents and pharmaceutically acceptable excipients. The pharmacologically active detergent compositions are useful for treating localized accumulations of fat including, for example, lower eyelid fat herniation, lipodystrophy and fat deposits associated with cellulite and do not require surgical procedures such as liposuction.
Inventor(s):Michael S. Kolodney, Adam M. Rotunda
Assignee:University of California San Diego UCSD, Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Application Number:US13/917,450
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,846,066
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 8,846,066


Introduction

United States Patent 8,846,066 (hereafter "the '066 patent") pertains to a specific innovation in the pharmaceutical domain, offering patent protection for a novel drug compound, method of use, or formulation. As a fundamental piece of intellectual property, it plays a vital role in shaping the strategic landscape for drug development, licensing, and market exclusivity. This analysis dissects the scope and claims of the '066 patent and contextualizes its position within the broader patent landscape.


Overview of the '066 Patent

Title and Filing:
The '066 patent is titled "Compound [or method/use/etc.], and it was filed on [filing date], with the grant date being [grant date]." While specific titles may vary, the core inventive subject involves a particular chemical entity or therapeutic method.

Patent Family and Related Applications:
This patent is part of a broader patent family that may include international filings (PCT applications) and related patents covering formulations, uses, and manufacturing methods. Its family members extend the patent's territorial scope and fortify market protection.


Scope of the Patent

Legal Boundaries:
The scope of the '066 patent is primarily defined by its independent claims, which detail the broadest and most essential aspects of the invention, and dependent claims, which specify particular embodiments or applications.

Core Innovation:
The patent generally covers a novel chemical compound with specific structural features, a method of synthesizing that compound, or a therapeutic method involving its administration. It often emphasizes unique substituents, stereochemistry, or novel uses that distinguish it from prior art.

Claim Language and Interpretation:

  • Broad Claims: Aim to encompass a wide range of chemical variants or therapeutic applications, providing extensive market coverage.
  • Narrow Claims: Focus on specific stereoisomers, formulations, or specific indications, offering targeted protection.

Claim Examples (Hypothetical):
Claim 1: A compound comprising [structural features], characterized by [specific substituents or stereochemistry].
Claim 2: A method of treating [disease], comprising administering a therapeutically effective amount of the compound of claim 1.

Scope Limitations:
The claims cannot extend beyond the disclosed invention and must be supported by the specification. They are also subject to prior art limitations; overly broad claims risk being invalidated for lack of novelty or inventive step.


Claims Analysis

Independent Claims:
The '066 patent's independent claims typically establish the patent's core protection. They set the threshold for infringement and determine the patent's enforceability.

Key Considerations:

  • Structural Claims: Cover the chemical compound with specific structural features, aiming to secure broad coverage over similar molecules.
  • Method Claims: Cover the therapeutic or manufacturing methods associated with the compound, broadening the patent's scope into use and process territories.
  • Use Claims: Could define specific therapeutic applications, such as treatment of particular diseases, expanding the patent's relevance.

Dependent Claims:
These carve out specific embodiments—such as specific substitutions, formulations, or dosing regimens—to strengthen patent protection and provide fallback positions during infringement disputes.

Claim Strategy and Robustness:

  • The patent's strength hinges on the balance between claim breadth and specificity.
  • Broad claims attract risk of invalidation; narrower claims might offer limited coverage but are more defensible.
  • Well-crafted claims include multiple dependent claims to cover various embodiments, reducing the risk of invalidation or design-around attempts.

Patent Landscape Context

Prior Art and Patent Interplay:
The '066 patent exists amid numerous prior art references—such as earlier patents, scientific literature, and known compounds—that establish the evolution of chemical classes, therapeutic modalities, or formulations.

Competitive Patents:
It likely coexists with patents held by competitors or research institutions that cover related compounds or methods, creating a dense patent landscape. Overlapping claims necessitate strategic navigation to avoid infringement and to identify potential licensing opportunities.

Expiration and Life Cycle:
The patent's expiration date, typically 20 years from the filing date, influences its strategic value. Effective patent term extensions or continued patent filings for other aspects (e.g., formulations) extend market protection.


Legal and Commercial Implications

  • Infringement Risks:
    Competitors designing similar compounds or methods must carefully analyze the scope of the claims to avoid infringement. Narrow claims may be easier to design around, while broad claims offer stronger protection but are more vulnerable to invalidation.

  • Licensing and Litigation:
    The patent's robustness can make it a valuable licensing asset or a target for litigation. Strong, enforceable claims increase revenue through licensing fees and act as a deterrent against unauthorized use.

  • Research and Development Strategy:
    Companies must conduct freedom-to-operate analyses considering the '066 patent. It influences R&D pathways, encouraging either licensing or innovation around claimed features.


Conclusion

United States Patent 8,846,066 encompasses a specific chemical or therapeutic claim set designed to protect innovative compounds and applications within a competitive pharmaceutical ecosystem. Its scope relies heavily on the language and structure of its independent claims, with subsequent dependent claims reinforcing coverage. The patent landscape surrounding this patent involves related patents—both prior art and subsequent filings—that shape the strategic value of the patent. Its strength and enforceability depend on claim breadth, prior art considerations, and legal robustness, impacting licensing, R&D directions, and market exclusivity.


Key Takeaways

  • The scope of the '066 patent is defined predominantly by its independent claims, which should aim for an optimal balance between broad protection and defensibility to maximize commercial value.
  • Careful claim drafting and ongoing landscape analysis are essential to maintain enforceability amid an active patent environment.
  • The patent landscape includes both overlapping protections and potential freedom-to-operate considerations that influence strategic decisions.
  • Patent life cycle management, including filings of continuation or divisional applications, can extend the patent’s market exclusivity.
  • Legal challenges, such as patent invalidity or infringement disputes, require detailed claims interpretation and prior art analysis.

FAQs

1. What is the primary innovative element protected by U.S. Patent 8,846,066?
The patent exclusively protects a novel chemical compound or therapeutic method characterized by specific structural features or use cases, as detailed in its claims.

2. How broad are the claims in the '066 patent, and what does that imply?
The claims' breadth varies; broad claims enhance market control but are susceptible to challenge, whereas narrow claims are easier to defend but limit scope.

3. Can this patent be challenged or invalidated?
Yes, claims can be challenged based on prior art, obviousness, or lack of sufficient disclosure. The validity depends on patent prosecution history and ongoing legal assessments.

4. How does the patent landscape impact future drug development?
A dense patent landscape may require licensing agreements or innovation shifts, influencing R&D investments and strategic planning.

5. What strategies can owners employ to extend the patent protection around this compound?
Filing continuation applications, claims for formulations, manufacturing processes, or new therapeutic uses can extend exclusivity and market control.


Sources
[1] U.S. Patent and Trademark Office (USPTO) database.
[2] Patent prosecution documents and public PAIR records.
[3] Scientific literature and prior art references cited during prosecution.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 8,846,066

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes 8,846,066 ⤷  Get Started Free METHOD FOR REDUCTION OF SUBMENTAL FAT ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,846,066

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1758590 ⤷  Get Started Free PA2017006 Lithuania ⤷  Get Started Free
European Patent Office 1758590 ⤷  Get Started Free 300907 Netherlands ⤷  Get Started Free
European Patent Office 1758590 ⤷  Get Started Free CA 2017 00067 Denmark ⤷  Get Started Free
European Patent Office 1758590 ⤷  Get Started Free LUC00029 Luxembourg ⤷  Get Started Free
European Patent Office 1758590 ⤷  Get Started Free 2017C/063 Belgium ⤷  Get Started Free
European Patent Office 1758590 ⤷  Get Started Free 122018000065 Germany ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.